Tiny doses for tiny arms:  Pfizer applies for EUA for its COVID vaccine in kids 5-and-younger -- Why does the Bay Area manage COVID outbreaks so much better than L.A.? - podcast episode cover

Tiny doses for tiny arms: Pfizer applies for EUA for its COVID vaccine in kids 5-and-younger -- Why does the Bay Area manage COVID outbreaks so much better than L.A.?

Feb 01, 202210 min
--:--
--:--
Listen in podcast apps:
Metacast
Spotify
Youtube
RSS

Episode description

Pfizer has formally submitted its COVID vaccine to the FDA for emergency use authorization for use in children ages 5 and younger. Scientists have had a tough time perfecting the vaccine dosage for little bodies--strong enough to illicit an immune response against coronavirus but not too strong to bring on side effects. So we'll take a closer look.

Here in California we just had a battle of NorCal vs. SoCal, but that was in football with the Rams and 49ers going at it in the NFC Championship. The Rams won that round--but when it comes to the battle of controlling COVID, the Bay Area is blowing away Los Angeles--we'll explain.

To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy

Learn more about your ad choices. Visit https://podcastchoices.com/adchoices

For the best experience, listen in Metacast app for iOS or Android
Open in Metacast
Tiny doses for tiny arms: Pfizer applies for EUA for its COVID vaccine in kids 5-and-younger -- Why does the Bay Area manage COVID outbreaks so much better than L.A.? | The On Deadline Podcast - Listen or read transcript on Metacast